KRAS and neoplasm: Similarly, tumor cells defective in the RAS/KRAS pathway interact with immune cells in the TME by secreting a series of cytokines, such as TGF-β, IL-8, and IL-6, which are involved in macrophage reprogramming and the regulation of Treg differentiation166.